glp 1 afib New research presented at #HRS2026 finds #GLP1 medications may reduce the risk of #AFib — independent of weight loss. The findings suggest these therapies may influence heart rhythm through mechanisms beyond weight GLP-1 receptor agonists and myocardial

Urothelial dysfunction and chronic inflammation in patients with spinal cord injuries at different levels and correlation with urodynamic findings

Our Expert Take While GLP-1s are designed for long-term use, stopping and restarting them is possible with the right plan and support

The severity of hypoglycemia isnt determined by how low the blood sugar level is, but by the symptoms

Potential for oxidative imbalance if misused (although glutathione is generally well tolerated when used correctly)

GLP-1 agonists are most often used by people with type 2 diabetes to manage blood sugar levels, but in recent years, theyve become a top treatment choice for people with overweight or obesity for weight management